MENU
JUN 06, 2017 8:00 AM PDT

The new generation in immunoassays

Sponsored by: Thermo Fisher Scientific
Speaker
  • Senior R&D Manager and Immunoassay Strategy Lead, Biosciences Division, Thermo Fisher Scientific
    Biography
      David's Ph.D. and postdoctoral work focused on the study of G protein-coupled receptor signaling and thrombosis. Following his academic training, he led multiplexed immunoassay automation efforts at a Luminex® partnering company. In 2009, David joined Thermo Fisher Scientific working on the development of novel immunoassay platforms such as the ProtoPlex™ Immune Response Assay. Now as Sr. Manager and immunoassay strategy lead, David pursues next-gen immunoassay platform development which includes working with translational investigators to identify serum-based biomarkers in cancer, autoimmunity, and inflammation.

    Abstract

    DATE: June 6, 2017
    TIME: 8:00am PT, 11:00am ET

    Early detection of protein biomarkers is critical to the study of human disease (cancer, neurobiology, inflammation/autoimmunity, etc). Basic research scientists, as well as translational investigators seek sensitive protein quantitation tools that provide low-level detection of disease relevant protein analytes. The enzyme-­linked immunosorbant assay (ELISA) first developed in the 1970s and slightly improved upon over the years, is still considered the gold standard for specific protein quantitation. However, large sample consumption, limited sensitivity, and laborious workflows associated with ELISA methods leave room for improvement and new innovation. 

    Thermo Fisher Scientific, the worldwide leader in life science tools for researchers, is unveiling an affordable new platform for the next generation of high­sensitivity, ready-to-use immunoassays. Featuring serum compatible, TaqMan™ based proximity ligation assay (PLA) and Siteclick™ antibody labeling technologies, this new assay combines the analyte specificity of high affinity antibody-antigen binding with the signal detection and amplification of real-time PCR. Not only does this assay technique allow measurement of low expressing proteins that we may not have otherwise been able to detect, but it also provides an easy method to verify gene expression at a protein level. 

    In this webinar, we will address the following items related to this new platform: 

    • Small sample consumption – uses 2-5 µL of sample (for example, 2uL vs 150uL for triplicate wells with other methods)  
    • High-sensitivity – detect low levels of proteins with greater sensitivity than other traditional methods 
    • Large dynamic range – 5 logs or greater minimizes guessing associated with sample dilutions
    • Fast, easy workflow – no wash steps, 2 hours from sample to answer. Step 1: Mix samples with antibodies and incubate. Step 2: Add master mix reagents and place into real time PCR instrument.
    • No proprietary instrument to purchase - Runs on any real time PCR instrument – no need for specialized equipment
    • Includes intuitive free cloud-enabled software – for robust data analysis and statistical groupwise comparison
    • Publishing - The importance of validation for publishing purposes
    • Q & A with the expert

     


    Show Resources
    You May Also Like
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    DEC 16, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 16, 2020 8:00 AM PST
    Date: December 16, 2020 Time: 8:00am (PST), 11:00am (EST) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data to better under...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    JUN 06, 2017 8:00 AM PDT

    The new generation in immunoassays

    Sponsored by: Thermo Fisher Scientific

    Specialty

    Immunology

    Molecular Biology

    Cell Biology

    Cancer Research

    Biotechnology

    Laboratory Testing

    Clinical Diagnostics

    Molecular Diagnostics

    Biomarkers

    Biochemistry

    Infectious Disease

    Cell Culture

    Assay Development

    Microbiology

    Antibodies

    Geography

    North America68%

    Europe18%

    Asia6%

    South America3%

    Africa1%

    Registration Source

    Website Visitors100%

    Job Title

    Scientist17%

    Research Scientist16%

    Student11%

    Executive10%

    Educator/Faculty8%

    Facility/Department Manager8%

    Lab Management7%

    Post Doc7%

    Medical Laboratory Technician5%

    Clinical Laboratory Scientist4%

    Medical Doctor/Specialist4%

    Biologist2%

    Microbiologist1%

    Marketing/Sales1%

    Organization

    Academic Institution10%

    Biotech Company7%

    Clinical Laboratory6%

    Hospital6%

    Research Institute4%

    Pharmaceutical Company4%

    Life Science Company3%

    Contract Research Organization (Cro)1%

    Ambulatory Care1%

    Medical Center1%

    Government1%

    Medical Device Company1%

    Medical School1%

    Industrial Company1%

    Other3%


    Show Resources
    Loading Comments...
    Show Resources